heartdiseasefacts.com
[ad_1]
Timmis A, Vardas P, Townsend N, Torbica A, Katus H, De Smedt D, Gale CP, Maggioni AP, Petersen SE, Huculeci R, et al. European Society of Cardiology: Cardiovascular Disease Statistics 2021. Eur Heart J. 2022;43(8):716–99.
Ormazábal V, Neel S, Elfeky O, Aguayo C, Solomon C, Zuniga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovascular diabetes. 2018;17(1):1
Hill MA, Yang Y, Zhang L, Sun Z, Jia G, Parrish AR, Sowers JR. Insulin resistance, cardiovascular stiffness, cardiovascular disease. metabolism. 2021;119:154766.
Unger G, Benozzi SF, Peruzza F, Pennacchiotti GL. Triglyceride and glucose index: useful indicators of insulin resistance. Endocrine neutral. 2014;61(10):533–40.
Hong S, Han K, Park CY. Triglyceride glucose index is a simple and low-cost marker associated with atherosclerotic cardiovascular disease. This is a group-based study. BMC Medicine. 2020;18(1):361.
Wang L, Cong HL, Zhang JX, Hu YC, Wei A, Zhang YY, Yang H, Ren LB, Qi W, Li WY et al. Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndromes. To do. Cardiovascular diabetes. 2020;19(1):80.
Wang X, Xu W, Song Q, Zhao Z, Meng X, Xia C, Xie Y, Yang C, Jin P, Wang F. Association between triglyceride-glucose index and severity of coronary artery disease. Cardiovascular diabetes. 2022;21(1):168.
Grant PJ, Cosentino F, Marx N. Diabetes and coronary artery disease: More than just risk factors. heart. 2020;106(17):1357–64.
Tai S, Fu L, Zhang N, Yang R, Zhou Y, Xing Z, Wang Y, Zhou S. Association between cumulative triglyceride-glucose index and major adverse cardiovascular events in patients with type 2 diabetes. Cardiovascular diabetes. 2022;21(1):161.
Li T, Wang P, Wang X, Liu Z, Zhang Z, Zhang Y, Wang Z, Feng Y, Wang Q, Guo X, et al. Inflammation and insulin resistance in patients with diabetic chronic coronary syndrome. Nutrients 2023, 15(12).
Lee SE, Sung JM, Andreini D, Al-Mallah MH, Budoff MJ, Cademartiri F, Chinnaiyan K, Choi JH, Chun EJ, Conte E, et al. Association between changes in perivascular adipose tissue density and plaque progression. JACC Cardiovascular Imaging. 2022;15(10):1760–7.
Antonopoulos AS, Sanna F, Sabharwal N, Thomas S, Oikonomou EK, Herdman L, Margaritis M, Shirodaria C, Kampoli AM, Akoumianakis I, et al. Detect inflammation in human coronary arteries by imaging fat around blood vessels. Sci Transl Med 2017, 9(398).
Oikonomou EK, Marwan M, Desai MY, Mancio J, Arashi A, Hat-Centeno E, Thomas S, Hardman L, Kotanidis CP, Thomas KE, et al. Noninvasive detection of coronary artery inflammation and prediction of residual cardiovascular risk using computed tomography (CRISP CT study): Post hoc analysis of predictive outcome data. Lancet. 2018;392(10151):929–39.
Lin A, Nerlekar N, Yuvaraj J, Fernandes K, Jiang C, Nichols SJ, Day D, Wong DTL. Computed tomography attenuation of pericoronary adipose tissue distinguishes different stages of coronary artery disease: a cross-sectional study. Eur Heart J Cardiovascular Imaging. 2021;22(3):298–306.
Geller M, Achenbach S, Cadet S, Kwan AC, Commandor F, Slomka PJ, Granthal H, Albrecht MH, Tamarapou BK, Berman DS, et al. Computed tomographic attenuation of pericoronary adipose tissue and high-risk plaque characteristics in acute coronary syndromes compared with stable coronary artery disease. JAMA Cardiol. 2018;3(9):858–63.
Jin A, Wang S, Li J, Wang M, Lin J, Li H, Meng X, Wang Y, Pan Y. Mediation of systemic inflammation on insulin resistance and prognosis of non-diabetic stroke patients. stroke. 2023;54(3):759–69.
Tan N, Dey D, Marwick TH, Nerlekar N. Pericoronary adipose tissue as a marker of cardiovascular risk: This week’s topic of JACC review. J Am Col Cardiol. 2023;81(9):913–23.
Diabetes in America A. 2. Diabetes Classification and Diagnosis: Diabetes Medical Standards – 2021. diabetes care. 2021;44(Supplement 1):15–S33.
Imai K, Keele L, Tingley D. A general approach to causal mediation analysis. psycho method. 2010;15(4):309–34.
Cho YR, Ann SH, Won KB, Park GM, Kim YG, Yang DH, Kang JW, Lim TH, Kim HK, Choe J, et al. Associations between insulin resistance, hyperglycemia, and coronary artery disease according to the presence of diabetes. . Sci Rep. 2019;9(1):6129.
Zhang Y, Wang R, Fu X, Song H. Non-insulin-based insulin resistance index in predicting coronary artery disease severity. Diabetic metatab syndrome. 2022;14(1):191.
Su J, Li Z, Huang M, Wang Y, Yang T, Ma M, Ni T, Pan G, Lai Z, Li C et al. Severity of coronary artery disease in various glucose metabolic states in patients with coronary heart disease. Triglyceride-glucose index for detection: RCSCD-TCM study in China. Cardiovascular diabetes. 2022;21(1):96.
Ghosh A, Gao L, Thakur A, Siu PM, Lai CWK. The role of free fatty acids in endothelial dysfunction. J Biomed Sci. 2017;24(1):50.
Bai B, Yang Y, Wang Q, Li M, Tian C, Liu Y, Aung LHH, Li PF, Yu T, Chu XM. NLRP3 inflammasome in endothelial dysfunction. Cell Death Disorders 2020;11(9):776.
Yalibeygi H, Farrokhi FR, Butler AE, Sahebkar A. Insulin resistance: a review of the underlying molecular mechanisms. J Cell Physiol. 2019;234(6):8152–61.
Kong P, Cui ZY, Huang XF, Zhang DD, Guo RJ, Han M. Inflammation and atherosclerosis: signaling pathways and therapeutic interventions. Signal transfer target heat. 2022;7(1):131.
Takashi Inoguchi, P. Li, F. Umeda, HY Yu, S. Kakimoto, M. Imamura, T. Aoki, T. Eto, T. Hashimoto, M. Naruse et al. High glucose levels and free fatty acids are associated with protein kinase C-dependent NAD ( Stimulates the production of reactive oxygen species through activation of P)H oxidase. Diabetes mellitus. 2000;49(11):1939–45.
Bian K, Doursout MF, Murad F. Vascular system: the role of nitric oxide in cardiovascular disease. J Clin Hypertens (Greenwich). 2008;10(4):304–10.
Laakso M, Kuusisto J. Insulin resistance and hyperglycemia in the development of cardiovascular disease. Nat Rev Endocrinology. 2014;10(5):293–302.
Puschel GP, Klauder J, Henkel J. Macrophages, low-grade inflammation, insulin resistance, and hyperinsulinemia: an ambiguous relationship between each other in the development of metabolic diseases. J Clin Med 2022, 11(15).
Libby P. Inflammation during the life cycle of atherosclerotic plaques. Cardiovascular Institute 2021;117(13):2525–36.
Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, et al. Anti-inflammatory therapy with canakinumab for atherosclerosis. N Eng J Med 2017;377(12):1119–31.
Tardif JC, Kouz S, Waters DD, Beltran OF, Diaz R, Maggioni AP, Pinto FJ, Ibrahim R, Gamla H, Kiwan GS, et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N Eng J Med 2019;381(26):2497–505.
Tong DC, Quinn S, Nasis A, Hiew C, Roberts-Thomson P, Adams H, Sriamareswaran R, Htun NM, Wilson W, Stub D, et al. Colchicine in patients with acute coronary syndrome: the Australian COPS randomized clinical trial. Circulation. 2020;142(20):1890–900.
Ma R, Ties D, van Assen M, Pelgrim GJ, Sidorenkov G, van Oijen PMA, van der Hurst P, van Dijk R, Vliegenthart R. Towards a reference value for pericoronary adipose tissue attenuation: coronary artery and tube voltage Affected coronary artery computed tomography angiography. Eur Radiol. 2020;30(12):6838–46.
[ad_2]
Source link
